Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.

Gnant, Michael F X; Mlineritsch, Brigitte; Luschin-Ebengreuth, Gero; Grampp, Stephan; Kaessmann, Helmut; Schmid, Marianne; Menzel, Christian; Piswanger-Soelkner, Jutta Claudia; Galid, Arik; Mittlboeck, Martina; Hausmaninger, Hubert; Jakesz, Raimund

Gnant, Michael F X; Mlineritsch, Brigitte; Luschin-Ebengreuth, Gero; Grampp, Stephan; Kaessmann, Helmut; Schmid, Marianne; Menzel, Christian; Piswanger-Soelkner, Jutta Claudia; Galid, Arik; Mittlboeck, Martina; Hausmaninger, Hubert; Jakesz, Raimund.

Affiliation

Gnant MF; Department of Surgery, General Hospital, Medical University of Vienna, Vienna, Austria. michael.gnant@meduniwien.ac.at

J Clin Oncol ; 25(7): 820-8, 2007 Mar 01.

Article in En | MEDLINE | ID: mdl-17159195

Subject(s)

Antineoplastic Agents/adverse effects; Aromatase Inhibitors/adverse effects; Breast Neoplasms/drug therapy; Diphosphonates/therapeutic use; Goserelin/adverse effects; Imidazoles/therapeutic use; Nitriles/adverse effects; Osteoporosis, Postmenopausal/prevention & control; Tamoxifen/adverse effects; Triazoles/adverse effects; Adult; Anastrozole; Bone Density/drug effects; Diphosphonates/adverse effects; Female; Humans; Imidazoles/adverse effects; Middle Aged; Zoledronic Acid

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Tamoxifen / Triazoles / Breast Neoplasms / Osteoporosis, Postmenopausal / Goserelin / Aromatase Inhibitors / Diphosphonates / Imidazoles / Antineoplastic Agents / Nitriles Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2007 Type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links